A 2013 review in Journal of Neurotrauma shows that even mild hyperbaric oxygen therapy (m-HBOT) at 1.3 ATA produces measurable biological effects. Benefits include reduced inflammation, enhanced oxygen delivery, and improved recovery—proving m-HBOT is safe, effective, and far from placebo.
For years, hyperbaric therapy at low pressures was dismissed as insignificant — even labeled a “placebo” in some clinical research. But a detailed review by Dr. Paul Harch, published in the Journal of Neurotrauma, systematically dismantles that misconception. His analysis shows that even very slight increases in pressure — as low as 1.04 ATA — can trigger physiological effects that are anything but inert.
What the Study Found
Study Title: Hyperbaric Oxygen Therapy: Oxygen and Gene Therapy View Full Study →
Author: Dr. Paul G. Harch, MD
Published In: Journal of Neurotrauma (2013)
Key Findings:
Dr. Harch reviewed dozens of clinical and preclinical studies and concluded that any pressure above ambient (1.0 ATA) delivers a measurable “dose” of oxygen — which alters gene expression, reduces inflammation, and supports healing.
Pressures as low as 1.04 ATA triggered biological changes, including enhanced oxygen transport and cellular responses, contradicting the long-standing assumption that low pressures were ineffective.
The paper calls out prior studies that labeled m-HBOT a placebo as flawed in design, with improper control groups and inadequate understanding of pressure physics.
“The data show that hyperbaric oxygen therapy is not about the pressure alone or the oxygen alone — it’s about the combination,” Harch writes. “And that combination begins to work at much lower levels than previously recognized.”
Why It Matters
For clients using or considering HBOT, this study confirms what many have experienced firsthand: even mild pressures deliver real results. Whether you’re recovering from injury, supporting cognitive performance, or addressing inflammation, the biological effects begin well before 2.0 ATA.
This is especially important for those using soft chambers, which typically operate at 1.3 ATA. According to the evidence, that’s more than enough to deliver measurable physiological benefits — and it’s consistent with the pressures used in many of the successful protocols referenced in Dr. Harch’s review.
Mild vs. High-Pressure HBOT: A Quick Comparison
Feature
Mild HBOT (1.3 ATA)
Traditional HBOT (2.0+ ATA)
Oxygen Delivery
Increased O₂ via modest pressure
Higher O₂ concentration under greater pressure
Primary Use
Wellness, recovery, inflammation, cognitive support
Acute medical conditions (e.g., wound healing, carbon monoxide poisoning)
Equipment Type
Soft-sided chambers
Hard-shell chambers
Accessibility
Home or wellness center
Hospitals and specialized clinics
Risk Profile
Extremely low
Higher — requires medical oversight
Session Comfort
Gentle pressure, low noise
Higher pressure, medical setting
Bottom line: The therapeutic effects of HBOT are not exclusive to hospital-grade hard chambers. Mild HBOT offers a safe, comfortable, and biologically effective option — especially for long-term recovery, brain health, and performance optimization.
Read full study →
Read more scientific studies →
Interested in adding HBOT to your business or wellness protocol?
Let’s talk about how BH Labs can support you.
Contact us to learn more or request a demo.
—
BH Labs Recovery Pods package these clinically-studied modalities into one turnkey system — starting at $49K.
Talk to Us